BR112022012998A2 - Composição e terapia para tratamento de reflexos faríngeos - Google Patents

Composição e terapia para tratamento de reflexos faríngeos

Info

Publication number
BR112022012998A2
BR112022012998A2 BR112022012998A BR112022012998A BR112022012998A2 BR 112022012998 A2 BR112022012998 A2 BR 112022012998A2 BR 112022012998 A BR112022012998 A BR 112022012998A BR 112022012998 A BR112022012998 A BR 112022012998A BR 112022012998 A2 BR112022012998 A2 BR 112022012998A2
Authority
BR
Brazil
Prior art keywords
therapy
treatment
composition
pharyngeal
reflexes
Prior art date
Application number
BR112022012998A
Other languages
English (en)
Portuguese (pt)
Inventor
Olson Robert
Olson Deshka
Provost Wayne
Original Assignee
Orion Innovations Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Innovations Inc filed Critical Orion Innovations Inc
Publication of BR112022012998A2 publication Critical patent/BR112022012998A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR112022012998A 2019-12-30 2020-12-11 Composição e terapia para tratamento de reflexos faríngeos BR112022012998A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962954966P 2019-12-30 2019-12-30
US17/100,677 US20210196748A1 (en) 2019-12-30 2020-11-20 Composition and therapy for treatment of gag reflexes
PCT/US2020/064604 WO2021138025A1 (en) 2019-12-30 2020-12-11 Composition and therapy for treatment of gag reflexes

Publications (1)

Publication Number Publication Date
BR112022012998A2 true BR112022012998A2 (pt) 2022-09-06

Family

ID=76545400

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022012998A BR112022012998A2 (pt) 2019-12-30 2020-12-11 Composição e terapia para tratamento de reflexos faríngeos

Country Status (7)

Country Link
US (5) US20210196748A1 (https=)
EP (1) EP4084869A4 (https=)
JP (3) JP7492772B2 (https=)
KR (1) KR102671524B1 (https=)
AU (1) AU2020417185B2 (https=)
BR (1) BR112022012998A2 (https=)
WO (1) WO2021138025A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210196748A1 (en) * 2019-12-30 2021-07-01 Robert Olson Composition and therapy for treatment of gag reflexes

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB954241A (en) * 1961-05-11 1964-04-02 Koopmans Meelfabrieken N V Process for the production of ready-for-use soups and sauces in powdered form
ZA73467B (en) * 1972-02-25 1973-10-31 Hoffmann La Roche Mineral salts containing preparation
US4068006A (en) * 1976-10-07 1978-01-10 Akzona Incorporated Salt seasoning mixture
US4414198A (en) * 1982-04-23 1983-11-08 Joseph Michaelson Rapidly disintegrable tablet composition and method
US4634591A (en) * 1985-09-06 1987-01-06 Westerman Robert D Anti-gagging compositions and method of treating gagging reflexes
DE10015662A1 (de) * 2000-03-29 2001-10-04 Henkel Kgaa Zahnpflegemittel in Portionskapseln
US7799342B2 (en) * 2000-12-06 2010-09-21 Wyeth Llc Fast dissolving tablet
US20050019277A1 (en) * 2002-09-11 2005-01-27 The Procter & Gamble Company Tooth whitening products
US7989016B2 (en) * 2006-10-05 2011-08-02 Sambasiva Rao Chigurupati Method for producing a low sodium salt composition
RU2345773C2 (ru) * 2007-01-30 2009-02-10 ФГУ Новосибирский научно-исследовательский институт травматологии и ортопедии (ФГУ ННИИТО Росздрава) Способ ингаляционной анестезии с минимальным газотоком
US20120088971A1 (en) * 2008-03-19 2012-04-12 Hanu Surgical Devices Llc ROTICAM: An Orotracheal Guide with Camera
CA2893780A1 (en) * 2008-04-15 2009-10-22 Trudell Medical International Swallowing air pulse therapy mouthpiece and method for the use thereof
US10556011B2 (en) * 2011-12-02 2020-02-11 Joshua D. Levine Method and system for adding sensory conditioning cues in a pharmacotherapeutic regimen
PL3473248T3 (pl) * 2012-09-11 2022-07-25 Norgine Bv Kompozycje zawierające glikol polietylenowy i siarczany metali alkalicznych lub metali ziem alkalicznych do zastosowania jako kompozycje do oczyszczania jelita grubego
US20140335153A1 (en) * 2013-05-09 2014-11-13 Cure Pharmaceutical Corporation Thin film with high load of active ingredient
EP3131433A1 (en) * 2014-05-07 2017-02-22 Colgate-Palmolive Company Oral care system
US20160271120A1 (en) * 2015-03-17 2016-09-22 Oakdene Holdings Llc Pharmaceutical composition for cleansing of the gastrointestinal tract
CN106420810A (zh) * 2016-09-27 2017-02-22 天津市聚星康华医药科技有限公司 一种补液盐口腔溶解膜及其制备方法
CN108354068A (zh) * 2018-05-24 2018-08-03 张继成 一种多功能畜禽补水溶液及其制备方法
US10857092B2 (en) 2019-03-14 2020-12-08 Glen D Lindbo Avoiding gag reflex to enable swallowing pills
KR102245629B1 (ko) * 2019-04-10 2021-04-30 주식회사 제네웰 히알루론산계 녹는 필름, 이의 제조방법 및 이에 사용되는 이형지
US20210196748A1 (en) * 2019-12-30 2021-07-01 Robert Olson Composition and therapy for treatment of gag reflexes
CN112042908A (zh) * 2020-09-14 2020-12-08 湖南雨泉农业发展有限公司 一种无糖保健型葛粉果冻及其制作方法

Also Published As

Publication number Publication date
WO2021138025A1 (en) 2021-07-08
AU2020417185B2 (en) 2026-03-12
JP2024105427A (ja) 2024-08-06
JP7492772B2 (ja) 2024-05-30
US20230025472A1 (en) 2023-01-26
JP2023516851A (ja) 2023-04-21
KR102671524B1 (ko) 2024-05-31
US11813286B2 (en) 2023-11-14
EP4084869A1 (en) 2022-11-09
US11701383B2 (en) 2023-07-18
AU2020417185A1 (en) 2022-07-21
US20210260105A1 (en) 2021-08-26
US20230024303A1 (en) 2023-01-26
US20230414652A1 (en) 2023-12-28
KR20220122680A (ko) 2022-09-02
US20210196748A1 (en) 2021-07-01
CA3163259A1 (en) 2021-07-08
EP4084869A4 (en) 2024-02-14
US11458162B2 (en) 2022-10-04
JP2025166003A (ja) 2025-11-05
JP7724579B2 (ja) 2025-08-18

Similar Documents

Publication Publication Date Title
CY1125520T1 (el) Μεθοδοι θεραπειας αμυλοειδωσης που διαμεσολαβειται με τρανσθυρετινη (ttr)
BR112020017090A8 (pt) Imunoterapias relacionadas com microbioma
BR112015003188A2 (pt) Composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente
MX393855B (es) Terapia de combinación que comprende un inhibidor de raf y trametinib
BR112016020199A8 (pt) composto inibidor de calicreína plasmática de humano, composição farmacêutica compreendendo o referido composto, kit e seu uso
MX2021003905A (es) Composicion de liberacion modificada de orlistat y acarbosa para el tratamiento de la obesidad y trastornos metabolicos relacionados.
MX382162B (es) Combinaciones farmacéuticas de un inhibidor de enzima hdac con un inhibidor de proteasoma, y su uso en el tratamiento de cáncer.
MX2023014492A (es) Compuestos utiles en la terapia para el vih.
TW201613578A (en) Pharmaceutical combinations
PH12016502352A1 (en) Pharmaceutical composition
ZA202002626B (en) Use of riluzole prodrugs to treat ataxias
MD4710B1 (ro) Tratamente terapeutice pe bază de anamorelin
BR112017016378A2 (pt) composições da pró-droga de fumarato de monometila
BR112018069682A2 (pt) métodos de tratamento para doenças colestáticas e fibróticas
PH12021550671A1 (en) Prodrugs of cgrp antagonists
BR112019005456A2 (pt) composição farmacêutica e método para tratamento de esteatose hepática não alcoólica
EA201200428A1 (ru) Композиция и способ для лечения ожирения
EA201792264A1 (ru) Способы лечения воспалительных заболеваний
MX389282B (es) Composiciones y métodos para tratar sinucleinopatías.
BR112018007768A2 (pt) composições e métodos para tratamento de homocistinúria
BR112022012998A2 (pt) Composição e terapia para tratamento de reflexos faríngeos
ZA201906153B (en) Pharmaceutical compositions for combination therapy
CL2021000858A1 (es) Derivados de 4-pirazin-2-ilmetil-morfolina y su uso como medicamento
MX2022007738A (es) Procesos e intermedios sinteticos.
BR112017002449A2 (pt) tratamento de sintomas associados com terapia de privação androgênica

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]